CytomX Therapeutics, Inc. reports

Company location: South San Francisco, CA
Fiscal year end: 31 December

CytomX Therapeutics, Inc. has filed 794 SEC EDGAR filings since 28 Sep 2010

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 176-200 of 794 matching filings.

Per page

25

Current page

8

4

4 filing

Filing date: 19 Jan 2024
Reporting date: 18 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 Jan 2024
Reporting date: 18 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 Jan 2024
Reporting date: 18 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 Jan 2024
Reporting date: 18 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 Jan 2024
Reporting date: 18 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Dec 2023
Reporting date: 20 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Dec 2023
Reporting date: 20 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Dec 2023
Reporting date: 20 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Dec 2023
Reporting date: 20 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Dec 2023
Reporting date: 20 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 Dec 2023
Reporting date: 17 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 Dec 2023
Reporting date: 17 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 Dec 2023
Reporting date: 17 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 Dec 2023
Reporting date: 17 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 19 Dec 2023
Reporting date: 17 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37587

8-K

Filing date: 07 Nov 2023
Reporting date: 07 Nov 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-37587

10-Q

Filing date: 07 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 22 Sep 2023
Reporting date: 20 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Sep 2023
Reporting date: 20 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Sep 2023
Reporting date: 20 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Sep 2023
Reporting date: 20 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

424B3 File 333-274010

424B3

Filing date: 28 Aug 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-274010

EFFECT filing

Filing date: 25 Aug 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37587

8-K

Filing date: 24 Aug 2023
Reporting date: 08 Aug 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 23 Aug 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .